Litcius/Paper detail

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials

Jim M Smit, Philip van der Zee, Sara C. M. Stoof, Michel E. van Genderen, Dominic Snijders, Wim Boersma, Paola Confalonieri, Francesco Salton, Marco Confalonieri, Mei‐Chiung Shih, G. Umberto Meduri, Pierre François Dequin, Amélie Le Gouge, Melanie Lloyd, Harin Karunajeewa, Grzegorz Bartminski, Silvia Fernández-Serrano, Guillermo Suárez-Cuartín, David van Klaveren, Matthias Briel, Christof Schönenberger, Ewout W. Steyerberg, Diederik Gommers, Hannelore I. Bax, Willem Jan W. Bos, E.M.W. van de Garde, Esther Wittermans, Jan C. Grutters, C Blum, Mirjam Christ‐Crain, Antoní Torres, Ana Motos, Marcel Reinders, Jasper van Bommel, Jesse H. Krijthe, Henrik Endeman

2025The Lancet Respiratory Medicine52 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboInternal medicineRandomized controlled trialPneumoniaClinical endpointAdjuvant therapyOdds ratioCorticosteroidClinical trialAdjuvantIntention-to-treat analysisSurgeryCancerAlternative medicinePathologyPneumonia and Respiratory InfectionsNosocomial Infections in ICUSepsis Diagnosis and Treatment
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials | Litcius